MENU
+Compare
PRAX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$76.43
Change
+$3.59 (+4.93%)
Capitalization
1.43B

PRAX Praxis Precision Medicines Forecast, Technical & Fundamental Analysis

Industry Biotechnology
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PRAX with price predictions
Dec 20, 2024

PRAX in downward trend: 10-day moving average broke below 50-day moving average on December 13, 2024

The 10-day moving average for PRAX crossed bearishly below the 50-day moving average on December 13, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PRAX entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where PRAX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 19, 2024. You may want to consider a long position or call options on PRAX as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRAX just turned positive on December 20, 2024. Looking at past instances where PRAX's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

PRAX moved above its 50-day moving average on December 20, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRAX advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.727) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). PRAX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (714.286) is also within normal values, averaging (256.215).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PRAX is expected to report earnings to fall 91.94% to -22 cents per share on March 13

Praxis Precision Medicines PRAX Stock Earnings Reports
Q4'23
Est.
$-0.22
Q3'24
Missed
by $0.76
Q2'24
Beat
by $0.57
Q3'23
Beat
by $0.08
Q2'23
Missed
by $6.69
The last earnings report on November 06 showed earnings per share of -275 cents, missing the estimate of -199 cents. With 530.84K shares outstanding, the current market capitalization sits at 1.43B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
99 High Street
Phone
+1 617 300-8460
Employees
82
Web
https://www.praxismedicines.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGSX24.350.34
+1.42%
Fidelity Series Growth Company
MMUGX22.170.29
+1.33%
MFS Utilities R1
SECAX11.160.11
+1.00%
SEI Small Cap II A (SIIT)
TQGIX17.980.13
+0.73%
T. Rowe Price Integrated Global Eq I
COSAX9.87-0.01
-0.10%
Columbia Overseas Core A

PRAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with ZYME. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+5.05%
ZYME - PRAX
38%
Loosely correlated
+4.12%
STRO - PRAX
35%
Loosely correlated
+3.30%
VERU - PRAX
35%
Loosely correlated
+3.20%
CLRB - PRAX
35%
Loosely correlated
-1.26%
MRSN - PRAX
35%
Loosely correlated
-8.05%
More